Integrated Nanotherapeutics
PrivateLast Round
Grant
Mar 18, 2026
Total Funding Raised
$140,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Integrated Nanotherapeutics is a biotechnology company that is developing a new class of therapeutics for antigen-specific immune tolerance using its proprietary multi-cargo lipid nanoparticles (LNPs) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Integrated Nanotherapeutics Comparables
Compare Integrated Nanotherapeutics with similar companies based on industry and business-model similarity.
Integrated Nanotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 18, 2026 | ||||
| Grant | Sep 9, 2024 | ||||
| Accelerator | Jun 1, 2023 | ||||
| Accelerator | Apr 1, 2023 | ||||
| Grant | Mar 18, 2019 |
Integrated Nanotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Western Economic Diversification Canada | Grant |
| Genome British Columbia | Grant |
| Creative Destruction Lab | Accelerator |
| National Research Council Canada Industrial Research Assistance Program | Accelerator |
| JDRF | Grant |
| Life Sciences BC | Accelerator |
| The University of British Columbia | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors increased 90% MoM.
- Mar 18, 2026
Received grant funding from Genome British Columbia and Genome Canada.
Integrated Nanotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Integrated Nanotherapeutics's valuation, stock price, and market status.